Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 27 Gynecologic 2 Thoracic 1 Other solid neoplasm 1 Dermatologic 1

Conditions

Advanced Solid Tumor 1

Interventions

pembrolizumab 26 Pemetrexed 26 Cisplatin 25 Nivolumab 22 Carboplatin 16 Paclitaxel 14 Gemcitabine 12 Ipilimumab 11 tislelizumab 8 durvalumab 8 Ramucirumab 8 Docetaxel 8 talazoparib 7 Fluorouracil 7 Radiotherapy 6 Capecitabine 6 tremelimumab 5 cobimetinib 5 atezolizumab 5 adavosertib 5 Radiosurgery 5 Cyclophosphamide 5 Bevacizumab 5 olaparib 4 avelumab 4 Temozolomide 4 Sunitinib 4 Specimen Handling 4 Platinum 4 PM 01183 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × IFL protocol × Other solid neoplasm × Clear all

NCT05147350 2025-12-05

MINOTAUR

Debiopharm International SA

Phase 1 Terminated

38 enrolled 17 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡